Back to Journals » ImmunoTargets and Therapy » Volume 13 » default
ImmunoTargets and Therapy
- View all (339)
- Volume 15, 2026 (37)
- Volume 14, 2025 (90)
- Volume 13, 2024 (56)
- Volume 12, 2023 (14)
- Volume 11, 2022 (6)
- Volume 10, 2021 (30)
- Volume 9, 2020 (27)
- Volume 8, 2019 (5)
- Volume 7, 2018 (10)
- Volume 6, 2017 (8)
- Volume 5, 2016 (8)
- Volume 4, 2015 (17)
- Volume 3, 2014 (14)
- Volume 2, 2013 (13)
- Volume 1, 2012 (3)
Archive: Volume 13, 2024
Immune Checkpoint Inhibitor Combined with Antiangiogenic Agent Synergistically Improving the Treatment Efficacy for Solid Tumors
Zhou Y, Liu Z, Yu A, Zhao G, Chen B
ImmunoTargets and Therapy 2024, 13:813-829
Published Date: 31 December 2024
Anti-GluK2 Encephalitis in an Asian Child: A Case Report and Literature Review
Chen S, Kessi M, He F, Yin F, Peng J, Yang L
ImmunoTargets and Therapy 2024, 13:805-811
Published Date: 17 December 2024
Lipopolysaccharide in Bile Promotes the Neutrophil Extracellular Traps-Induced Gallstone Formation by Activating the Gallbladder Immune Barrier
Yu J, Meng Z, Liu X, Zheng Y, Xue D, Hao C, Wang L
ImmunoTargets and Therapy 2024, 13:789-803
Published Date: 17 December 2024
NLRP3 Inflammasome Upregulates PD-L1 in Ovarian Cancer and Contributes to an Immunosuppressive Microenvironment
Pan W, Jia Z, Du J, Chang K, Liu Y, Liu W, Zhao X, Tan W
ImmunoTargets and Therapy 2024, 13:775-788
Published Date: 14 December 2024
Microbiome Differences in Colorectal Cancer Patients and Healthy Individuals: Implications for Vaccine Antigen Discovery
Ibeanu GC, Rowaiye AB, Okoli JC, Eze DU
ImmunoTargets and Therapy 2024, 13:749-774
Published Date: 13 December 2024
TRPC6 is a Biomarker for Prognosis and Immunotherapy of Stomach Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation
Hu X, Wang H, Sun H, Zhang J, Ye Z, Huang Z
ImmunoTargets and Therapy 2024, 13:735-748
Published Date: 12 December 2024
Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Based on EcoTyper Machine Learning Framework Identifies Cell-State-Specific M2 Macrophage Markers Associated with Gastric Cancer Prognosis
Zhu AK, Li GY, Chen FC, Shan JQ, Shan YQ, Lv CX, Zhu ZQ, He YR, Zhai LL
ImmunoTargets and Therapy 2024, 13:721-734
Published Date: 11 December 2024
Advances in B Cell Targeting for Treating Muscle-Specific Tyrosine Kinase-Associated Myasthenia Gravis
Hu G, Zhao X, Wang Y, Zhu X, Sun Z, Yu X, Wang J, Liu Q, Zhang J, Zhang Y, Yang J, Chang T, Ruan Z, Lv J, Gao F
ImmunoTargets and Therapy 2024, 13:707-720
Published Date: 11 December 2024
Evolution of Hematobiochemical Profiles in Newly Diagnosed HIV Patients and HIV-TB Co-Infected Patients: Correlation with Immunological and Virological Status
Khan NH, Verma C, Beg MMA, Kumar SN, Kaushik G, Ahmad H, Osmonaliev K, Kumar V
ImmunoTargets and Therapy 2024, 13:691-705
Published Date: 10 December 2024
The Potential Value of RPS27A in Prognosis and Immunotherapy: From Pan-Cancer Analysis to Hepatocellular Carcinoma Validation
Kuai X, Wei C, He X, Wang F, Wang C, Ji J
ImmunoTargets and Therapy 2024, 13:673-690
Published Date: 8 December 2024
Diminished Diversities and Clonally Expanded Sequences of T-Cell Receptors in Patients with Chronic Spontaneous Urticaria
He X, Wen X, He PM, Liang D, Yang L, Ran Y, Zhang Z
ImmunoTargets and Therapy 2024, 13:661-671
Published Date: 5 December 2024
Circ_0001944 Targets the miR-1292-5p/FBLN2 Axis to Facilitate Sorafenib Resistance in Hepatocellular Carcinoma by Impeding Ferroptosis
Jing F, Shi Y, Jiang D, Li X, Sun J, Guo Q
ImmunoTargets and Therapy 2024, 13:643-659
Published Date: 26 November 2024
Novel Insights into Causal Effects of Lipid and Lipid-Lowering Targets with Autoimmune Thyroid Disease: A Mendelian Randomization Study
Su C, Tian J, He X, Chang X, Wang G, Liu J
ImmunoTargets and Therapy 2024, 13:631-641
Published Date: 23 November 2024
Causality Between 91 Circulating Inflammatory Proteins and Various Asthma Phenotypes: A Mendelian Randomization Study
Zhang S, Zhang X, Wei C, Zhang L, Li Z
ImmunoTargets and Therapy 2024, 13:617-629
Published Date: 2 November 2024
Identification of CRTH2 as a New PPARγ-Target Gene in T Cells Suggested CRTH2 Dependent Conversion of Th2 Cells as Therapeutic Concept in COVID-19 Infection
Becker A, Röhrich K, Leske A, Heinicke U, Knape T, Kannt A, Trümper V, Sohn K, Wilken-Schmitz A, Neb H, Adam EH, Laux V, Parnham MJ, Onasch V, Weigert A, Zacharowski K, von Knethen A
ImmunoTargets and Therapy 2024, 13:595-616
Published Date: 2 November 2024
The Effect of Circulating Inflammatory Proteins on Endometriosis: A Mendelian Randomization Study
Wei Y, Zhao X, Li L
ImmunoTargets and Therapy 2024, 13:585-593
Published Date: 1 November 2024
Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment
Shang X, Zhang C, Lv Y, Zhang X, Guo K, Li H, Wang H
ImmunoTargets and Therapy 2024, 13:571-583
Published Date: 26 October 2024
The Efficacy and Safety of Bevacizumab Plus Anti-PD-1/PD-L1 Inhibitors in Combination with Hepatic Arterial Infusion Chemotherapy for Initially Unresectable Hepatocellular Carcinoma
Tang X, Chen J, Peng W, Yang Z, Hu L, Ye Z, Fu Y, Hu D, Zhou Z, Chen M, Zhang Y, Wang JC
ImmunoTargets and Therapy 2024, 13:559-569
Published Date: 26 October 2024
Assessing the Prognostic Value of 13 Inflammation-Based Scores in Patients with Unresectable or Advanced Biliary Tract Carcinoma After Immunotherapy
Wang F, Jiang C, He W, Li H, Guo GF, Xu L
ImmunoTargets and Therapy 2024, 13:541-557
Published Date: 16 October 2024
Harnessing Variability Signatures and Biological Noise May Enhance Immunotherapies’ Efficacy and Act as Novel Biomarkers for Diagnosing and Monitoring Immune-Associated Disorders
Sigawi T, Israeli A, Ilan Y
ImmunoTargets and Therapy 2024, 13:525-539
Published Date: 14 October 2024
A Self-Activating IL-15 Chimeric Cytokine Receptor to Empower Cancer Immunotherapy
Chen S, Yang L, Xia B, Zhu H, Piao Z, Jounaidi Y
ImmunoTargets and Therapy 2024, 13:513-524
Published Date: 10 October 2024
Clinical Outcomes of Patients Treated with Ribociclib in Combination with Aromatase Inhibitors or Fulvestrant for HR-Positive, HER2-Negative Metastatic Breast Cancer, Real-World Data from a Low-Resourced Country
Abdel-Razeq H, Sharaf B, Khater S, Baidoun HJ, Bani Hani H, Taqash A, El Khatib O, Edaily S, Abunasser M, Tamimi F, Al-Masri YN, Al-Batsh TMW, Zayed A, Ghatasheh T, Radaideh T
ImmunoTargets and Therapy 2024, 13:501-512
Published Date: 29 September 2024
EPS T14 from Bacillus licheniformis Prevents Infection of Human Nasal Epithelial Cells by Respiratory Viruses
Pezzino G, Calabrò A, Drommi F, Campana S, Cavaliere R, Bonaccorsi I, Carrega P, Zammuto V, Rizzo MG, Gugliandolo C, Ferlazzo G, De Pasquale C
ImmunoTargets and Therapy 2024, 13:487-499
Published Date: 27 September 2024
Thrombopoietin Receptor Agonists in Post-Hematopoietic Cell Transplantation Complicated by Prolonged Thrombocytopenia: A Comprehensive Review
Elsayed A, Elsayed B, Elmarasi M, Elsabagh AA, Elsayed E, Elmakaty I, Yassin M
ImmunoTargets and Therapy 2024, 13:461-486
Published Date: 13 September 2024
Survival Benefit of Lenvatinib Plus PD-1 Inhibitor with or Without HAIC in Advanced Hepatocellular Carcinoma Beyond Oligometastasis: a Multicenter Cohort Study
Wang M, Zhou Q, Li H, Liu M, Li R, Wang W, Wang X, Huang J, Duan F
ImmunoTargets and Therapy 2024, 13:447-459
Published Date: 9 September 2024
Clinical Significance and Molecular Annotation for PD-L1 Negative Advanced Non-Small Cell Lung Cancer with Sensitivity to Responsive to Dual PD-1/CTLA-4 Blockade
Wang L, Liu L, Zhao J, Yu X, Su C
ImmunoTargets and Therapy 2024, 13:435-445
Published Date: 6 September 2024
Revolutionizing Immunotherapy: Unveiling New Horizons, Confronting Challenges, and Navigating Therapeutic Frontiers in CAR-T Cell-Based Gene Therapies
Srivastava S, Tyagi A, Pawar VA, Khan NH, Arora K, Verma C, Kumar V
ImmunoTargets and Therapy 2024, 13:413-433
Published Date: 27 August 2024
Addition of Immune Checkpoint Inhibitor Showed Better Efficacy for Infiltrative Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion Chemotherapy and Lenvatinib: A Multicenter Retrospective Study
Wang W, Li R, Li H, Wang M, Wang J, Wang X, Zhou Q
ImmunoTargets and Therapy 2024, 13:399-412
Published Date: 19 August 2024
Clinical Features and Pathology of PLA2R and THSD7A-Associated Membranous Nephropathy: A Single-Center Study from China
Pan Y, Chen WD, Liu L, Yang H, Chang B, Cui C
ImmunoTargets and Therapy 2024, 13:385-398
Published Date: 25 July 2024
Optimal Assessment, Treatment, and Monitoring of Adults with Eosinophilic Esophagitis: Strategies to Improve Outcomes
Visaggi P, Ghisa M, Vespa E, Barchi A, Mari A, Pasta A, Marabotto E, de Bortoli N, Savarino EV
ImmunoTargets and Therapy 2024, 13:367-383
Published Date: 24 July 2024
Mapping Single-Cell Transcriptomes of Endometrium Reveals Potential Biomarkers in Endometrial Cancer
Xu G, Pan T, Li S, Guo J, Zhang Y, Xu Q, Chen R, Ma Y, Li Y
ImmunoTargets and Therapy 2024, 13:349-366
Published Date: 16 July 2024
A Case Report of Pathologically Complete Response of a Huge Lymph Node Metastasis of Colorectal Cancer After Treatment with Intratumoral Oncolytic Virus H101 and Capecitabine
Wang Y, Wang T, Zhang Y
ImmunoTargets and Therapy 2024, 13:343-348
Published Date: 4 July 2024
Mycobacterium tuberculosis Biofilms: Immune Responses, Role in TB Pathology, and Potential Treatment
Assefa M, Girmay G
ImmunoTargets and Therapy 2024, 13:335-342
Published Date: 3 July 2024
Deciphering Natural Killer Cell Cytotoxicity Against Medulloblastoma in vitro and in vivo: Implications for Immunotherapy
Gauthier M, Pierson J, Moulin D, Mouginot M, Bourguignon V, Rhalloussi W, Vincourt JB, Dumas D, Bensoussan D, Chastagner P, Boura C, Decot V
ImmunoTargets and Therapy 2024, 13:319-333
Published Date: 26 June 2024
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis
Xu K, Xiang C, Yu Z, Li J, Liu C
ImmunoTargets and Therapy 2024, 13:305-317
Published Date: 17 June 2024
Advances in the Understanding of the Correlation Between Neuroinflammation and Microglia in Alzheimer’s Disease
Yan H, Wang W, Cui T, Shao Y, Li M, Fang L, Feng L
ImmunoTargets and Therapy 2024, 13:287-304
Published Date: 12 June 2024
Mendelian Randomization Analysis of Circulating Cytokines and Risk of Autoimmune Neuroinflammatory Diseases
Tao SS, Cao F, Zhang RD, Xu SZ, Li XX, Tang J, Yang XK, Pan HF
ImmunoTargets and Therapy 2024, 13:273-286
Published Date: 10 June 2024
Targeted siRNA Therapy for Psoriasis: Translating Preclinical Potential into Clinical Treatments
Zhao F, Zhao J, Wei K, Jiang P, Shi Y, Chang C, Zheng Y, Shan Y, Li Y, He B, Zhou M, Liu J, Li L, Guo S, He D
ImmunoTargets and Therapy 2024, 13:259-271
Published Date: 16 May 2024
Efficacy of Lenvatinib Combined with PD-1 Inhibitor versus Sorafenib and PD-1 Inhibitor with or Without TACE for Hepatocellular Carcinoma with Extrahepatic Metastasis
Duan WB, Wang XH, Zhang GC, He Z, Li SQ, Zhou J
ImmunoTargets and Therapy 2024, 13:247-258
Published Date: 16 May 2024
The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review
Berhan A, Damtie S, Almaw A, Legesse B, Sharew B, Getie B, Erkihun M, Solomon Y
ImmunoTargets and Therapy 2024, 13:235-246
Published Date: 26 April 2024
Clinical Significance of Uncommon, Non-Clinical, and Novel Autoantibodies
Shurin MR, Wheeler SE
ImmunoTargets and Therapy 2024, 13:215-234
Published Date: 25 April 2024
Correlation Between C4/IgG with Macroproteinuria in Chronic Kidney Disease: A Pilot Study
Zhang H, Xu A, Li X, Pan B, Wan X
ImmunoTargets and Therapy 2024, 13:205-214
Published Date: 12 April 2024
Comprehension of Calcitriol Levels in Pregnant Women With Latent Tuberculosis and Immune Function in their Newborns
Meirina F, Sari DK, Lubis IND, Daulay RS, Yani FF, Lubis BM, Sembiring RJ, Pandia P, Rusda M, Amin MM
ImmunoTargets and Therapy 2024, 13:195-204
Published Date: 8 April 2024
Thymic NK-Cells and Their Potential in Cancer Immunotherapy
Forbes C, Nierkens S, Cornel AM
ImmunoTargets and Therapy 2024, 13:183-194
Published Date: 25 March 2024
Cold Tumour Phenotype Explained Through Whole Genome Sequencing in Clinical Nasopharyngeal Cancer: A Preliminary Study
Handoko, Adham M, Rachmadi L, Wibowo H, Gondhowiardjo SA
ImmunoTargets and Therapy 2024, 13:173-182
Published Date: 18 March 2024
Dermatomyositis: Practical Guidance and Unmet Needs
Cassard L, Seraly N, Riegert M, Patel A, Fernandez AP
ImmunoTargets and Therapy 2024, 13:151-172
Published Date: 6 March 2024
Efficacy and Safety Profile of Tuberculin Protein Purified Derivative Injection As Immunotherapy For the Treatment of Cutaneous and Anogenital Warts: A Review Article
Achdiat PA, Suwarsa O, Hidayat YM, Shafiee MN, Dwiyana RF, Hindritiani R, Sutedja E, Pudjiati SR, Hilmanto D, Dhamayanti M, Parwati I, Maharani RH, Sutedja EK, Avriyanti E, Yunitasari
ImmunoTargets and Therapy 2024, 13:123-150
Published Date: 5 March 2024
Characterizing CD8+ TEMRA Cells in CP/CPPS Patients: Insights from Targeted Single-Cell Transcriptomic and Functional Investigations
Zhang F, Ge Q, Meng J, Chen J, Liang C, Zhang M
ImmunoTargets and Therapy 2024, 13:111-121
Published Date: 26 February 2024
Chronic Inflammatory Demyelinating Polyradiculoneuropathy: Current Therapeutic Approaches and Future Outlooks
Rajabally YA
ImmunoTargets and Therapy 2024, 13:99-110
Published Date: 26 February 2024
Males’ Access to Human Papillomavirus Vaccination in Resource-Limited Settings
Gezimu W, Bekele F, Bekana T, Demeke A
ImmunoTargets and Therapy 2024, 13:95-98
Published Date: 17 February 2024
The Age-Male-Albumin-Bilirubin-Platelets (aMAP) Risk Score Predicts Liver Metastasis Following Surgery for Breast Cancer in Chinese Population: A Retrospective Study
Chen L, Liu Q, Tan C, Wu T, Wu M, Tan X, Liu J, Wang J
ImmunoTargets and Therapy 2024, 13:75-94
Published Date: 8 February 2024
Identification of CXC Chemokine Receptor 2 (CXCR2) as a Novel Eosinophils-Independent Diagnostic Biomarker of Pediatric Eosinophilic Esophagitis by Integrated Bioinformatic and Machine-Learning Analysis
Wu J, Duan C, Han C, Hou X
ImmunoTargets and Therapy 2024, 13:55-74
Published Date: 2 February 2024
Inhibition Effect of Pancreatic Exocrine Insufficiency on Immune Checkpoint Inhibitor Treatment in Pancreatic Cancer: A Retrospective Study
Luo Q, Dong Y, Liu P, He C, Chen L, Zhang K, Pan C, Gao Y, Qin T
ImmunoTargets and Therapy 2024, 13:45-54
Published Date: 1 February 2024
Unveiling Dynamic Changes and Regulatory Mechanisms of T Cell Subsets in Sepsis Pathogenesis
Jiang C, Chen J, Sun T, Xu J, Zhu H, Chen J
ImmunoTargets and Therapy 2024, 13:29-44
Published Date: 1 February 2024
In-vivo Immunomodulatory Activities of Essential Oils of Artemisia abyssinica and Lepidium sativum in Mice
Ayenew KD, Ayalew A, Wondmkun YT, Tsige AW, Wolde A, Sewale Y, Belihu GD, Fekade E, Habteweld HA
ImmunoTargets and Therapy 2024, 13:15-27
Published Date: 23 January 2024
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer
Li Y, Gu Y, Yang P, Wang Y, Yu X, Li Y, Jin Z, Xu L
ImmunoTargets and Therapy 2024, 13:1-14
Published Date: 9 January 2024